Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

ETNB 89bio Forecast, Technical & Fundamental Analysis

a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases

Industry Biotechnology
ETNB
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For ETNB
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ETNB
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For ETNB
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

ETNB is expected to report earnings to fall 45.22% to -76 cents per share on March 19

89bio ETNB Stock Earnings Reports
Q4'24
Est.
$-0.76
Q3'24
Missed
by $0.77
Q2'24
Beat
by $0.08
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.01
The last earnings report on November 08 showed earnings per share of -138 cents, missing the estimate of -62 cents. With 493.69K shares outstanding, the current market capitalization sits at 1.03B.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
142 Sansome Street
Phone
+1 415 432-9270
Employees
70
Web
https://www.89bio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSCRX26.950.40
+1.51%
Fidelity Small Cap Discovery
COAGX53.080.60
+1.14%
Gator Capital L/S Fd
NMUAX10.940.08
+0.74%
Neuberger Berman Multi-Cap Opp A
PCUZX59.530.16
+0.27%
T. Rowe Price U.S. Equity Research Z
HMEZX19.860.02
+0.10%
NexPoint Merger Arbitrage Z

ETNB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+4.53%
AKRO - ETNB
63%
Loosely correlated
+4.90%
PLRX - ETNB
47%
Loosely correlated
+1.01%
IDYA - ETNB
46%
Loosely correlated
+0.71%
MDGL - ETNB
45%
Loosely correlated
+5.53%
NTLA - ETNB
44%
Loosely correlated
+3.62%
More